Paul B. Keiser, MD

name

Koren MA, Lin L, Eckels KH, Keiser PB, et al., Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial. Lancet Infect Dis. 2023 Oct;23(10):1175-1185. doi: 10.1016/S1473- 3099(23)00192-5. 3

topic

Yellow Fever Virus

name

Lin L, Koren MA, Paolino KM, Eckels KH, De La Barrera R, Friberg H, Currier JR, Gromowski GD, Aronson NE, Keiser PB, Sklar MJ, Sondergaard EL, Jasper LE, Endy TP, Jarman RG, Thomas SJ, Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial, J Infect Dis. 2021 May 28;223(10):1707-1716.

topic

Dengue Vaccine

name

Lin L, Lyke KE, Koren M, Jarman RG, Eckels KH, Lepine E, McArthur MM, Currier JR, Friberg H, Moris P, Keiser PB, De La Barrera R, Vaughn DW, Paris RM, Thomas SJ, Schmidt AC, Safety and immunogenicity of an AS03B-adjuvanted inactivated tetravalent dengue virus vaccine administered on varying schedules to healthy U.S. adults: A phase 1/2, randomized study, Am J Trop Med Hyg. 2020 Jul;103(1):132-141.

topic

Dengue Virus

name

Endy TP, Keiser PB, Wang D, Jarman RG, Cibula D, Fang H, Ware L, Abbott M, Thomas SJ, Polhemus ME, Serologic Response of 2 Versus 3 Doses and Intradermal Versus Intramuscular Administration of a Licensed Rabies Vaccine for Preexposure Prophylaxis, J Infect Dis. 2020 Apr 7;221(9):1494-1498.

topic

Rabies Vaccine

name

Endy TP, Keiser PB, Cibula D, Thomas SJ, Ware L, Polhemus ME, Effect of Antimalarial Drugs on the Immune Response to Intramuscular Rabies Vaccination Using a Post-Exposure Prophylaxis Regimen, J Infect Dis. 2020 Mar 2;221(6):927-933.

topic

Rabies Vaccination

name

Binn LN, Norby EA, Marchwicki RH, Jarman RG, Keiser PB, Hang J. Canine caliciviruses of four serotypes from military and research dogs recovered in 1963-1978 belong to two phylogenetic clades in the Vesivirus genus. Virol J. 2018 Feb 23;15(1):39.

topic

Research Dogs

name

Hang J, Zavaljevski N, Yang Y, Desai V, Ruck RC, Macareo LR, Jarman RG, Reifman J, Kuschner RA, Keiser PB. Composition and variation of respiratory microbiota in healthy military personnel. PLoS One. 2017; 12(12): e0188461.

topic

Healthy Military

name

Hang J, Vento TJ, Norby EA, Jarman RG, Keiser PB, Kuschner RA, Binn LN. Adenovirus type 4 respiratory infections with a concurrent outbreak of coxsackievirus A21 among United States Army Basic Trainees, a retrospective viral etiology study using nextgeneration sequencing. J Med Virol. 2017; 89(8):1387-1394.

topic

Viral Etiology

name

Norby EE, Jarman RG, Keiser PB, Binn LN, Hang J. Genome Sequence of a Novel Canine Picornavirus Isolated from an American Foxhound. Genome Announc. 2017 May 18;5(20). pii: e00338-17. - Moe CD, Keiser PB. Should U.S. troops routinely get rabies pre-exposure prophylaxis? Mil Med. 2014; 179(7): 702-3.

topic

Novel Canine

name

Payne KM, Keiser PB, Kaplan MR, Jones OY, Hyper IgD-syndrome presenting as Sweet's Syndrome in a 6 week old infant, Ann Paediatr Rheum. 2013; 2: 118-123.

topic

Hyper IgD-syndrome

name

Keiser PB, Gill CJ, Defining efficacy in meningococcal vaccine trials. Clin Invest. 2012; 2(6): 589–601. 4

topic

Meningococcal Vaccine

name

Keiser PB, Broderick M, Meningococcal polysaccharide vaccine failure in a patient with C7 deficiency and a decreased anti-capsular antibody response. Hum Vaccin Immunother. 2012; 8(5): 582-586.

topic

Polysaccharide Vaccine

name

Schmiel D, Moran EE, Keiser PB, Brandt B, Zollinger WD, Importance of Antibodies to Lipopolysaccharide in Natural and Vaccine-Induced Serum Bactericidal Activity against Neisseria meningitidis Group B, Infect Immun. 2011; 79(10): 4146-56.

topic

Vaccine-Induced Serum

name

Riddle MS, Kaminski RW, Williams C, Porter C, Baqar S, Kordis A, Gilliland T, Lapa J, Coughlin M, Soltis C, Jones E, Saunders J, Keiser PB, Ranallo RT, Gormley R, Nelson M, Turbyfill KR, Tribble D, Oaks EV. Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine. Vaccine. 2011; 29(40): 7009-19.

topic

Invaplex 50 Vaccine

name

Keiser PB, Hamilton L, Broderick M, U.S. Military Fatalities due to Neisseria meningitidis: Case Reports and Historical Perspective, Mil Med. 2011; 176(3): 308-11.

topic

Neisseria Meningitidis

name

Keiser PB, Biggs-Cicatelli S, Moran EE, Schmiel DH, Pinto VB, Burden RE, Miller LB, Moon JE, Bowden RA, Cummings JF, Zollinger WD, A Phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, overexpressed factor H binding protein, two porA’s and stabilized OpcA expression. Vaccine. 2011; 29(7): 1413-20.

topic

Membrane Vesicle Vaccine

name

Sheppard FR, Keiser P, Craft DW, Gage F, Robson M, Brown TS, Petersen K, Sincock S, Kasper M, Hawksworth J, Tadaki D, Davis TA, Stojadinovic A, Elster E, The majority of US combat casualty soft-tissue wounds are not infected or colonized upon arrival or during treatment at a continental U.S. military medical facility. Am J Surg. 2010; 200(4): 489-95.

topic

Military Medical Facility

name

Keiser PB, Gibbs BT, Coster TS, Moran EE, Stoddard MB, Labrie JE 3rd, Schmiel DH, Pinto V, Chen P, Zollinger WD, A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA. Vaccine 2010; 28: 6970-6.

topic

Membrane Vesicle Vaccine

name

Zollinger WD, Donets MA, Schmiel DH, Pinto VB, Labrie JE 3rd, Moran EE, Brandt BL, Ionin B, Marques R, Wu M, Chen P, Stoddard MB, Keiser PB, Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine, Vaccine 2010; 28:5 057–5067.

topic

Membrane Vesicle Vaccine

name

Stoddard MB, Pinto V, Keiser PB, Zollinger W. Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants, Clin Vaccine Immunol. 2010; 17(1): 98-107.

topic

Clin Vaccine Immunol

name

Keiser PB, Miller LB, Biggs-Cicatelli S, Zollinger WD. Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis, Vaccine, 2009; 27(49): 6809-13.

topic

Membrane Vesicle Vaccine

name

Keiser PB, Coulibaly YI, Kubofcik J, Diallo AA, Klion AD, Traore SF, Nutman TB, Molecular identification of Wolbachia from the filarial nematode Mansonella perstans, Mol Biochem Parasitol 2008; 160(2): 123-8.

topic

Mol Biochem Parasitol

name

Semnani RT, Keiser PB, Coulibaly YI, Keita F, Diallo AA, Traore D, Diallo DA, Doumbo OK, Traore SF, Kubofcik J, Klion AD, Nutman TB. Filaria-induced monocyte dysfunction and its reversal following treatment. Infect Immun. 2006; 74(8): 4409-17.

topic

Monocyte Dysfunction

name

Kerepesi LA, Keiser PB, Nolan TJ, Schad GA, Abraham D, Nutman TB. DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice. Infect Immun. 2005; 73(4): 2298-305.

topic

Strongyloides Stercoralis

name

Kerepesi LA, Nolan TJ, Schad GA, Lustigman S, Herbert DR, Keiser PB, Nutman TB, Krolewiecki AJ, Abraham D. Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice. J Infect Dis. 2004; 189(7): 1282-90.

topic

Strongyloides Stercoralis

name

Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised Population, Clin Microbiol Rev. 2004; 17(1): 208-17.

topic

Immunocompromised Population

name

Keiser PB, Coulibaly YI, Keita F, Traore D, Diallo A, Diallo D, Semnani RT, Traore SF, Doumbo OK, Klion AD, Nutman TB. Clinical Characteristics of Posttreatment Reactions to Ivermectin/Albendazole for Wuchereria bancrofti in a Region Co-Endemic for Mansonella perstans, Am J Trop Med Hyg. 2003; 69(3): 331-5.

topic

Wuchereria Bancrofti

name

Keiser PB, Nash TE. Prolonged Perilesional Edema Following Treatment of Parenchymal Neurocysticercosis: Methotrexate as a Steroid-Sparing Agent, Clin Infect Dis. 2003; 36(10): E122-6.

topic

Parenchymal Neurocysticercosis

name

Keiser PB, Reynolds SM, Awadzi K, Ottesen EA, Nutman TB. Bacterial Endosymbionts of Onchocerca volvulus in the Pathogenesis of Post Treatment Reactions, J Infect Dis. 2002; 185(6): 805-11.

topic

Clin Infect Dis

name

Keiser PB, Nutman TB. Update on Lymphatic Filarial Infections, Curr Inf Dis Reports. 2002; 4(1): 65-69.

topic

Curr Inf Dis Reports

name

Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA. Treatment of Refractory Giardiasis, Clin Infect Dis. 2001; 33(1): 22-8. OTHER PUBLICATIONS

topic

Refractory Giardiasis

name

Keiser PB, Nelson MR. Baseline differences explain the apparent benefits of combining oxymetazoline with intranasal corticosteroids. J Allergy Clin Immunol. 2011; 128(5): 1132. - Keiser PB, Mikita CP. Is physician-diagnosed allergic rhinitis a risk factor for the development of asthma? Pediatrics. 2011; 128: S115.

topic

Intranasal Corticosteroids

name

Labrie JE 3rd, Keiser PB. Whole cell vaccination for meningococcus: Lessons from an idea whose time has gone, Human Vaccines 2010; 6(4): 360-5.

topic

Meningococcus

name

Keiser PB, Nutman TB. Vaccines for Filarial Infections in World Class Parasites: the Filariae, edited by Klei TR and Rajan TV, Kluwer Academic Publishers, Boston, MA, 2002.

topic

Parasites